Expression Profile of Prostate-specific Antigen Messenger RNA by in ...

2 downloads 116 Views 2MB Size Report
of Prostate-specific. Antigen. Messenger. RNA. Assessed by in Situ Hybridization. Is a Novel Prognostic. Marker for Patients with Untreated. Prostate. Cancer1.
Vol. 4, 2187-2194,

September

Expression

Profile

of

by in Situ

Assessed

for Patients

Toshifumi

Clinical

1998

with

Hideki

Sakai,

Yutaka

Saito

Hybridization

Untreated

Takehiko

TSUTUSakI,2

Hiroshi

Prostate-specific

Kanetake,

Antigen Is a Novel

Prostate

0.001),

and

levels PSA and

Messenger

Prognostic

Research

2187

RNA

Marker

Cancer1

Koji,

Departments of Urology (T. T., H. S., H. K., Y. S.] and Histology Cell Biology IF. K.], Nagasaki University School of Medicine, Nagasaki 852-8501, Japan

Cancer

compared of PSA mRNA

with tumors

those Our

expressing low that analysis of in biopsy specimens

results

suggested

in specific areas untreated prostate cancer may of prognosis of prostate cancers.

expression

of patients good

with mRNA.

with

assessment

provide

a

INTRODUCTION PSA3

ABSTRACT

amino

The present tionship between prostate-specific

study

was

to define

undertaken

histological grade antigen (PSA) mRNA

(Gleason

the rein-

grade)

expression

and and to

of PSA mRNA expression as a possible for untreated prostate cancers. The primary grade areas of 104 prostatlc biopsy spedmens were anal for the expression ofPSA mRNA and Its protein by nonradioactive in situ hybridization and immunohistochemistry,

marker

respectively.

formed expression the

to

A multivariate

examine the correlation and several dlinicopathological

iminunostaining

mens. The percentage increased significantly

age analysis

survival

level of PSA of spedmens with

19 and

is secreted into

blood

protein

was

PSA parameters, in biopsy

in men

tumor

marker

mRNA e.g.,

degree

of differentiation that

of prostate

and poorly

cancer-specific

higher levels (representing death curves

high area

area

of PSA higher

of tumors

survival,

untreated

patients

with

expression in the higher grade of either primary or secondary were at high risk for cancer-related

mRNA grade

of PSA mRNA expression in the higher of tumors had a significantly poorer prognosis

PSA

groups,

12).

However,

degree

For

other

in patients

by 3.5

Stamey ng/ml

10 times

with benign including

ours,

the

prostatic reported

On the other hand, Hakalahti there was no difference in the level as well

as

et al.

(9)

for every higher

amount

cm3

than

that

of PSA

generally

in

decreases

tissue. A number of rethat poorly differentiated

between

of prostate

differentiated

as well

lower intensities of staining for PSA moderately differentiated tumors (10-

correlation

of differentiation

In

cancer, valuable

with prostate

volume,

example,

at least

of cancer

countries.

with prostate as the most

tumor

increases

a level

is in the

carcinomas

as by radioactive

PSA

synthesis

and

the

cancers is not well defined. et aL (10) demonstrated that of PSA

mRNA

as assessed

between

well

by Northern

blot-

ISH. Qui et al. (5) reported

previ-

expression detected by radioactive ISH was and malignant tissue samples, but the cxlower in cancer tissues than in benign epitheiurn, and

ously that PSA mRNA present in both benign pression

grade (P

(7).

tumors show significantly compared with well and

ting,

(P = 0.017). Furthermore, in cancer-specific survival based on PSA mRNA expression status, patients with levels

serum

with

of the prostate of PSA causes

many

in BPH. However, the relative cancer tissue, as measured by IHC,

observed prostate search

and

PSA levels

proportionately

cancer,

to analyze

grade)

intensity

between

States

(7, 8). Serum

increase

positive for PSA mRNA histological grade. Im-

part

and management of patients concentration is considered

cancer reported

cells

a small

in the liver (1-6). is one of the most frequent

per-

sped-

glycoprotein with 237 localized on chromosome

epitheial only

in the United

the screening serum PSA

in comparison

correlation

plasma;

and catabolized Prostate cancer

death

single-chain by a gene

by glandular

seminal

for PSA mRNA showed a the signal intensity in both primary and secondary grade areas of each specimen and the histological grade (P < 0.0001). Only 26.0% of spedmens positive for PSA protein were also positive for PSA mRNA (and vice versa, 6.7%). Other tumors were either positive for both (66.3%) or negative for both (1.0%). When the Cox’s proportional hazards regression model was used significant

of the signal

advanced

between

analysis

33,000 is encoded

Mr

that

mainly

the level

evaluate prognostic

is a

acids

=

was

that PSA mRNA expression tended to decrease in high-grade tumors, although this was statistically insignificant. Unfortunately, both studies did not assess the retention of hybridizable RNA in each

specimen,

too small entiation Received 3/30/98; accepted 6/19/98. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. I This work was supported by Grant-in-Aid 06404059 from the Miistiy of Education, Science, Sports and CUlture of Japan. 2 To whom requests for reprints should be addressed, at Department of Urology, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Phone: 81-95-849-7340; Fax: 81-95-8497343; E-mail: [email protected].

and

to define of prostate

In the present mRNA

in 109 cases

the number the relationship

of specimens between

in both

studies

the degree

was

of differ-

cancer and level of PSA mRNA expression. study, we investigated the expression of PSA with

benign

and

malignant

prostatic

tissue

The abbreviations used are: PSA, prostate-specific antigen; ISH, in situ hybridization; IHC, immunohistochemistry; BPH, benign prostatic hyperplasia T-T, thymine-thymine; ACS, automated chemibuminescence system. 3

2188 Expression

of PSA mRNA

samples

using

dimerized inalby

in Prostate

nonradioactive

ISH

oligodeoxynucleotide developed

sensitive

all specimens

laboratory

with

an excellent

used

in the

pression

Our

results

of PSA

marker

for

This was

were

orig-

45 bases

to be a very

637-681,

was

found (13).

examined

sufficient

RNA by ISH of 285 rRNA localized immunohistochemically that

in prostate

the

presence

cancers

(14).

In in

of high

may

cx-

be useful

complementary

as a

known

sequences.

thesized 3’-ends with

T-T

dimer.

AND

specimens with

were

prostate

versity

age ofthese

patients

In addition,

tate

June

from

performed at either

digital

18 gauge

needle ofthe

or transrectal a biopsy

biopsies

approach

specimen

tissue

was

not always

sections

were

coated

slides.

Informed

before

biopsy. All patients

were

given

with

mounted

gen. Mean endocrine

had

a luteinizing

evaluated

(histological level

PSA clinically

Tandem-R and Eiken

ACS-PSA Refs.

the

16),

PSA

Concentration.

Serum

by three

assay

different

PSA

cutoff

with

immuno-

described ized

and

Examination

were

stained

grade

of malignancy

with

H&E

was

determined

grading system (16), and secondary grades Higher

primary

grade

indicated

or secondary

Grading.

for pathological in each

40% tion.

Biopsy

specThe

using

the

a specimen grade.

of a high

grade

all

pretreated

with

citrate

20X

(pH 7.0)]

Tris-HCI

solution,

testicular

DNA

deionized

formamide.

at 37#{176}Cwith

(pH

500 p.g/ml

(Sigma

Chemical

The mem-

1 pjg/mi

T-T dimer-

tRNA,

and the sites

T-T

in the

sented

were PSA

salmon

testicular

of peroxidase

After as

were

visualHC1,

with

Sections

PSA

After

oligo-DNAs

medium

fixation

for PSA

as above.

formamide

stained were

hybridization

15 mm.

in 4X SSC until used for hybridizacarried out for 12 h at 37#{176}C with 2

50%

of peroxidase

to were This

in PBS for 5 rain, the sections were glycine in PBS for 30 mm and kept in

antisense

were

according

21). Briefly, sections standard procedures.

K at 37#{176}C for

hybridization

washed

was performed

(13, using

with 0.3% H202 in methanol for 15 peroxidase, 0.2 N HC1 for 20 rain,

proteinase

dimerized

in 2X

Then,

SSC,

followed

visualized was

and the

as described considered

slides by 2X

immunohistochemically,

signal

dis-

the

above. positive

when

the

black deposits in individual cells exceeded the level. When staining was almost similar to that of control,

the other hand, when the signal only.

pg/m1

3,3’-diaminobenzidine-4

ISH

Nonradioactive

solved

sites

125

and 40% deionized formamide. were stained immunochemically

described previously and rehydrated

pjg/mi

the sample

a strong

and

of strongly clear

Experiments mRNA

conducted antisense

was

considered

staining was classified was present but limited

A classification

ity of PSA of

10 mrs

and NiSO4(NH)2SO4.

Control

and the tissue area containing was selected for further investi-

containing

containing

deionized formamide Hybridization was

The

ng/

examination. sample

(21),

with 4% paraformaldehyde immersed in 2 mg/nil

were

17-19).

Pathological

yeast

a solution

ISH.

SSC. were

15.0

a

Japan).

specified,

M sodium

1 X Denhardt’s

overnight

previously

using

H2O2, Cod2

(ACS-PSA,

value,

Tokyo,

pg/m1

250

negative

ng/ml;

The

using

solution,

(normal